ARIANNE is a women owned business, with a highly experienced senior management team, each have a minimum of 15 years biopharmaceutical experience.

Cellia Habita, MD., PhD. Chief Executive Officer

Dr. Habita is the founder of ARIANNE and has moved the company from a consulting group to a full service clinical CRO. She has over fifteen years experience in research and development of human therapeutics. She brings her broad scientific and clinical expertise in various therapeutic areas such as oncology, dermatology, ophthalmology, endocrinology and infectious diseases. She has advanced multiple compounds through drug development from early pre-clinical to full clinical development. Dr. Habita has completed her general residency in Paris (France), she has a Master's in Biology and Genetics of Aging, and a PhD in genetics of Type I Diabetes. She completed her graduate research at the Welcome Trust Center in Oxford (Oxford University). After completing her post-graduate training at the University of California and holding the academic position of Assistant Project Scientist in the department of Pediatrics (USCD- San Diego), she moved into local Biotech where she headed Drug Development and Clinical and Regulatory teams as Director and Senior VP, respectively.

Jennifer Ellis Head of Regulatory Affairs

Jennifer is the co-founder of ARIANNE has over 18 years of regulatory experience in pharmaceuticals, biologics and devices. She has successfully submitted new drug submissions to the North American agencies and internationally. Jennifer has worked predominantly for small biotech start-up companies, running regulatory departments single-handedly as well as managing teams. She has contributed to clinical development, marketing, regulatory planning and administration and traveled the world extensively, monitoring and coordinating trials internationally. Her years of working in small environments have given her the opportunity to participate in all aspects of product development and utilize that experience in her writing, administration, development and corporate relationships.